Statement of Beneficial Ownership (sc 13d)
June 26 2017 - 12:40PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13D
Under
the Securities Exchange Act of 1934
TAURIGA
SCIENCES, INC.
(Name
of Issuer)
Common
Stock
(Title
of Class of Securities)
87669X106
(CUSIP
Number)
Seth
M. Shaw
c/o Tauriga Sciences, Inc.
39
Old Ridgebury Road
Danbury,
Connecticut 06180
(917) 796-9926
(Name,
Address and Telephone Number of Person Authorized to Receive Notices and Communications)
June
15, 2017
(Date
of Event which Requires Filing of this Statement)
If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
§240.13d-7 for other parties to whom copies are to be sent.
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.
The
information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
(1)
|
Names
of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)
|
|
|
|
Seth
M. Shaw
|
(2)
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(3)
|
SEC
Use Only
|
|
|
(4)
|
Source
of Funds (See Instructions)
|
|
|
|
PF
|
(5)
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ]
|
|
|
(6)
|
Citizenship
or Place of Organization
|
|
|
|
USA
|
|
(7)
|
Sole
Voting Power
|
|
|
|
Number
of
|
|
161,390,000
|
Shares
|
(8)
|
Shared
Voting Power
|
Beneficially
|
|
|
Owned
by
|
|
0
|
Each
|
(9)
|
Sole
Dispositive Power
|
Reporting
|
|
|
Person
|
|
161,390,000
|
With
|
(10)
|
Shared
Dispositive Power
|
|
|
|
|
|
0
|
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
|
|
|
161,390,000
|
(12)
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares [ ]
|
|
|
(13)
|
Percent
of Class Represented by Amount in Row (9)
|
|
|
|
8.08
|
(14)
|
Type
of Reporting Person (See Instructions)
|
|
|
|
IN
|
Item
1. Security and Issuer
Common
Stock. Tauriga Sciences, Inc., 39 Old Ridgeberry Road, Danbury, Connecticut 06180.
Item
2. Identity and Background
(a)
Seth
M. Shaw
(b)
39
Old Ridgeberry Road, Danbury, Connecticut 06180
(c)
Chief
Executive Officer and member of the Board of Directors of Tauriga Sciences, Inc., a Florida corporation.
(d)
N/A
(e)
N/A
(f)
USA
Item
3. Source and Amount of Funds or Other Consideration
One
June 15, 2017, Mr. Shaw purchased 76,000,000 shares of the Issuer’s Common Stock for an aggregate purchase price of $95,000,
or $0.00125 per shares. One June 21, 2017, Mr. Shaw purchased 44,000,000 shares of the Issuer’s Common Stock for an aggregate
purchase price of $55,000, or $0.00125 per shares. All such shares shall be “restricted securities” as such term is
defined by the Securities Act of 1933, as amended. The funds used for both purchase transaction were personal funds of Mr. Shaw.
Prior to the two transactions described above, Mr. Shaw owned 41,390,000 shares of the Issuer’s Common Stock. (See Item
5).
Item
4. Purpose of Transaction
Other
than the acquisition of additional securities of the Issuer in the ordinary course of business, Mr. Shaw does not have any plans
or proposals that would result in the matters enumerated in items (a) - (j) below.
(a) The acquisition by any person of additional
securities of the issuer, or the disposition of securities of the issuer;
(b)
An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries;
(c)
A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries;
(d)
Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number
or term of directors or to fill any existing vacancies on the board;
(e)
Any material change in the present capitalization or dividend policy of the issuer;
(f)
Any other material change in the issuer’s business or corporate structure, including but not limited to, if the issuer is
a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote
is required by section 13 of the Investment Company Act of 1940;
(g)
Changes in the issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition
of control of the issuer by any person; (*the Issuer is currently attempting to increase its number of authorized Common Stock
from 2.5 billion to 7.5 billion; however this action will not impeded the acquisition of control of the Issuer by any person)
(h)
Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to
be quoted in an inter-dealer quotation system of a registered national securities association;
(i)
A class of equity securities of the issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the
Act; or
(j)
Any action similar to any of those enumerated above.
Item
5. Interest in Securities of the Issuer.
(a)
As
of June 26, 2017, Mr. Shaw beneficially owned 161,390,000 shares of the Issuer’s Common Stock. The shares beneficially owned
by Mr. Shaw represented 8.08% of the issuer’s outstanding shares of Common Stock, as of June 23, 2017.
(b)
As
of June 26, 2017, Mr. Shaw had the sole power to vote and to dispose of 161,390,000 shares of the Issuer’s Common Stock.
(c)
One
June 15, 2017, Mr. Shaw purchased 76,000,000 shares of the Issuer’s Common Stock for an aggregate purchase price of $95,000,
or $0.00125 per shares. One June 21, 2017, Mr. Shaw purchased 44,000,000 shares of the Issuer’s Common Stock for an aggregate
purchase price of $55,000, or $0.00125 per shares. All such shares shall be “restricted securities” as such term is
defined by the Securities Act of 1933, as amended.
The
transactions described above were conducted privately and not through any exchange or public trading market.
(d)
N/A
(e)
N/A
Item
6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
None.
SIGNATURES
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Date:
June 26, 2017
|
By:
|
/s/
Seth M. Shaw
|
|
Name
:
|
Seth M. Shaw
|